Flash Sell! How YOU Profited From Being Part of the Biggest Tech Deal of All Time

By Ray BlancoPosted October 28, 2016

With a 20% gain in under 3 months, it’s time to sell this stock and take our profit while keeping an eye on it in the future.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

ImmunoGen Taps Important Milestone, Plus Updates on Isis, Vertex, Sarepta and VirnetX

By Ray BlancoPosted March 1, 2013

It's been a great week for our portfolio. One of our reccomendations has achieved a first in its history. This week, the FDA approved T-DM1, a new breast cancer compound co-developed with Roche/Genentech. The compound, which belongs to a class of therapies known as antibody-drug conjugates (ADCs), hitches Roche's popular breast cancer antibody, trastuzumab (Herceptin), to a powerful cancer-killing compound using a molecular link, both of which were developed by ImmunoGen. It has been in clinical development for seven years.

Portfolio News From the Biggest Cancer Research Event of the Year

By Ray BlancoPosted June 7, 2013

Running through last weekend, this year's annual meeting of the American Society of Clinical Oncology (ASCO) was an opportunity for companies, large and small, developing cancer therapies to share research findings with their peers. The ASCO meeting is, therefore, a great occasion to find out what's going on in the cancer research space. Since we have several cancer specialists in the Technology Profits Confidential portfolio, I'd like to update you on some of the items they presented at the event.

Are You Ready to Chitchat With Chatbots?

By Gerald CelentePosted July 29, 2016

Anyone who’s conversed with Apple’s Siri or Microsoft’s Cortana has made friends with a chatbot. Here’s why it’s the way of the future…

When to Expect Your Next Satellite Profit Play

By Ray BlancoPosted December 8, 2020

Right now, my team and I are putting the finishing touches on your next monthly issue. In it we share one publicly traded stock that stands to benefit from the launch of Elon Musk’s satellite internet, Starlink. But today, I want to take some time to answer some questions we received. Let’s jump right in…

Small Biotech Is Where It’s at in 2019

By Ray BlancoPosted March 22, 2019

The NBI is heavy in large-cap biotech and pharma companies, meaning that if one tumbles, it can really hit the index. Find out what that means for your portfolio…

How to Make the Most of Tech Profits

By Ray BlancoPosted February 24, 2021

We can’t seem to go more than a few days without Elon Musk’s Starlink making headlines. Musk took to Twitter Monday and claimed that Starlink will offer speeds of 300 Mbps by the end of 2021. That’s a big promise. But at the rate Starlink’s sending satellites up, they may just be able to do it.

Login